BJP releases manifesto for Karnataka polls, reaches out to farmers

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, Jun 28: A student appearing for the Secondary School Leaving Certificate (SSLC) exams in Kaup taluk of Udupi district has tested positive for the novel coronavirus (COVID-19) infection.

Officials of the Department of Public Instruction (DPI) and Udupi District Health and Family Welfare Department have confirmed the report. 

The 16-year-old girl had appeared for the Kannada and Mathematics exams on June 25 and 27 respectively. 

Her throat swabs were sent for testing on June 27 after her father tested covid-19 positive. Today she too obtained positive report.  

The student is unlikely to appear for the science paper on June 29.

Meanwhile, health officers have ruled out the possibility of subjecting other students to covid-19 test as all necessary precautions such as physical distancing and usage of sanitization were taken in the examination centre.

Mangaluru, Feb 12: Mangaluru City Corporation’s (MCC) mayoral elections will be held on February 28, Urban Development Department has announced.

Yashwanth V, Regional Commissioner of Mysuru will be conducting the election in the city.

The election will be held as per the 21st term reservation roster according to which the mayoral candidate has to be a BCM ‘A’ candidate and the deputy mayoral candidate must be a woman from the general category.